Additionally, the molecular classification from the Asian Cancer Research Group (ACRG) indicates that copy number variations (CNVs) in various genes, including HER2, are frequently encountered in the MSS/TP53 inactive group, where TP53 mutations are more prevalent [34]. This evidence concerns the gene ERBB2 and cancer.